Fresenius Medical Care AG & Co. KGaA (FMS) reported full-year 2012 net income attributable to shareholders of $1.19 billion, up 11 percent from full year 2011. Excluding a positive non-taxable investment gain in the amount of $140 million and one-time costs in the amount of $71 million, net income attributable to shareholders was $1.12 billion, an increase of 4 percent from prior year. Net revenue for the full year 2012 was $13.81 billion, up 10 percent from prior year.
Operating income, or EBIT, increased by 7 percent. Excluding one-time costs the operating income increased by 12%.
For the full year 2013, Fresenius Medical Care expects revenue to grow to more than $14.6 billion. Net income attributable to shareholders is expected to be between $1.1 billion and $1.2 billion. The company said, based on the net income for 2012 excluding the investment gain, the expected earnings growth in 2013 is between 5 percent and 15 percent.
The company also proposed an increased annual dividend. At the Annual General Meeting, shareholders will be asked to approve a dividend per ordinary share of 0.75 euros, an increase of 9% from prior year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.